CAERDAV LIMITED

1. Financial Health Score: D-

Explanation: Caerdav Limited is a patient with a severe, chronic underlying condition—deep insolvency—but is currently showing encouraging signs of operational recovery. While the business is technically insolvent with net liabilities exceeding £27 million, it is being kept alive on financial "life support" provided by its parent company and creditors. The robust 50% increase in revenue and improving cash reserves prevent this score from flatlining at an F, but the sheer weight of its liabilities poses a critical risk to its long-term survival.

2. Key Vital Signs

• Net Assets / Shareholders' Funds (Equity): -£27.2 million Interpretation: This is the equivalent of severe financial anemia. The company’s liabilities vastly exceed its assets. The patient has been bleeding losses for years, resulting in deeply negative equity. Without external life support, the business would be unable to survive.
• Turnover: £22.8 million (Up from £15.3 million) Interpretation: The patient’s pulse is getting stronger. A 50% increase in revenue is a fantastic vital sign, indicating that the core business—aircraft maintenance—is gaining market traction and scaling up successfully.
• Cash Position: £883,483 (Up from £267,981) Interpretation: Cash is the oxygen any business breathes. While still relatively low for a company of this turnover size, the 229% increase in cash reserves means the patient is finally getting more air, improving short-term operational resilience.
• Total Liabilities: £26.8 million Interpretation: Dangerously high blood pressure. The debt burden is massive compared to the asset base, requiring constant management and likely reliance on creditors not pulling the plug.

3. Diagnosis

Severe Chronic Insolvency with Acute Revenue Improvement

The financial data reveals a business that is technically insolvent but actively trading due to the implied support of its parent company, Cardiff Operating Group Limited, and other creditors. The accumulated losses have created a massive deficit on the balance sheet.

However, the "symptoms" are shifting. The strategic report highlights a move from 2 to 3 maintenance lines, driving the 50% revenue increase, with a 4th line launching in 2026 and turnover projected to exceed £30 million. The company is successfully fighting the disease of low revenue, but the historical scar tissue (accumulated debt) remains a massive obstacle to overall financial health. The fact that the company is actively investing in expansion and apprenticeships suggests management is confident in the ongoing financial life support provided by the parent company.

4. Recommendations

• Debt Restructuring Surgery: The most critical treatment is addressing the £27.2 million negative equity. The parent company (Cardiff Operating Group Limited) should look to perform financial surgery by converting substantial portions of shareholder debt into equity. This would reset the patient's baseline, clearing the negative equity and making the balance sheet look far healthier for future creditors and partners.
• Protect the Cash Flow Arteries: With £26.8 million in liabilities and less than £1 million in cash, the margin for error is razor-thin. As the business scales to 4 lines of maintenance, strict working capital management is essential. Delayed payments from customers or unexpected costs could quickly restrict the company's oxygen supply.
• Focus on Profitability, Not Just Revenue: Growing the top line is excellent, but revenue is only the pulse; profit is the actual health. As the company scales, it must ensure that the increased capacity translates to bottom-line net profit, which is desperately needed to eat away at the massive accumulated deficit.
• Monitor Creditor Vital Signs: With such high leverage, the company must maintain excellent relationships with its creditors. Any loss of confidence from lenders or the parent company could result in a withdrawal of life support, leading to immediate administration.